Mathis, Noah J.
Wijetunga, N. Ari
Imber, Brandon S.
Pike, Luke R. G.
Yang, Jonathan T.
Article History
Accepted: 12 November 2021
First Online: 8 February 2022
Declarations
:
: Noah J. Mathis has received funding for a research fellowship from eContour. Neil Ari Wijetunga declares that he has no conflict of interest. Brandon S. Imber declares that he has no conflict of interest. Luke R.G. Pike has received compensation for service as a consultant from Blackstone Investments/Clarus Ventures, Third Rock Ventures, Galera Therapeutics, Dynamo Therapeutics, Myst Therapeutics, Monte Rosa Therapeutics, and Best Doctors/Teladoc Inc., and owns stock/equity in Schrödinger, Novavax, and Clovis Oncology. Jonathan T. Yang declares that he has no conflict of interest.